Report: More than half of the world's population will be overweight/obese by 2035

Published Date: 08 Mar 2023

The World Health Organization's 2023 Atlas predicts that 51% of the world's population, or more than 4 billion people, will be overweight or obese within the next 12 years.

Read Full News

Latest News

1 in 9 Americans Now on GLP-1s

A recent Gallup poll shows that the use of GLP-1 drugs in the US has surged to a record high, with 11% of US adults currently using these medications and 15% reporting having used them at some point.

Manometry May Detect Hidden Reflux in Obesity

High-resolution impedance manometry identifies physiologic evidence of reflux in many patients with obesity whose gastroesophageal reflux disease may be missed on the basis of symptoms alone.

Exercise and Male Fertility: When Is More Too Much?

Moderate exercise supports semen quality and hormonal health, but prolonged high-intensity training may impair fertility, particularly when energy intake is inadequate.

Sleeve Gastrectomy and Hernia Repair Hold Up Long Term

Sleeve gastrectomy with hiatal hernia repair shows acceptable long-term outcomes, with postoperative reflux symptoms being associated with recurrence and need for reintervention.

Menopausal Hormone Therapy Tied to Risk for Eye Misalignment

Menopausal hormone therapy is linked to increased risks for diagnosis of and surgery for strabismus, and researchers detect estrogen receptor alpha in the human eye muscle.

New AI Imaging Detects ‘Striking’ Obesity-Related Neuropathy

Fascinating nervous system imaging reveals previously unseen obesity-related nerve damage in mice and humans — and some of it may be linked to GLP-1 use.

Todays Updates

PPI, Antibiotics May Curb Durvalumab Efficacy in NSCLC

Study adds to evidence that the widely used medications may interfere with immunotherapy efficacy via effects on the gut microbiome.

FDA Approves Subcutaneous Isatuximab for MM Indications

The drug can now be administered with the hands-free automated CirCLIQ on-body injector.

Todays Updates

PPI, Antibiotics May Curb Durvalumab Efficacy in NSCLC

Study adds to evidence that the widely used medications may interfere with immunotherapy efficacy via effects on the gut microbiome.

FDA Approves Subcutaneous Isatuximab for MM Indications

The drug can now be administered with the hands-free automated CirCLIQ on-body injector.

Latest News

A recent Gallup poll shows that the use of GLP-1 drugs in the US has surged to a record high, with 11% of US adults currently using these medications and 15% reporting having used them at some point.

High-resolution impedance manometry identifies physiologic evidence of reflux in many patients with obesity whose gastroesophageal reflux disease may be missed on the basis of symptoms alone.

Moderate exercise supports semen quality and hormonal health, but prolonged high-intensity training may impair fertility, particularly when energy intake is inadequate.

Sleeve gastrectomy with hiatal hernia repair shows acceptable long-term outcomes, with postoperative reflux symptoms being associated with recurrence and need for reintervention.

Menopausal hormone therapy is linked to increased risks for diagnosis of and surgery for strabismus, and researchers detect estrogen receptor alpha in the human eye muscle.

Fascinating nervous system imaging reveals previously unseen obesity-related nerve damage in mice and humans — and some of it may be linked to GLP-1 use.

News All Time

Hypoglycaemia Not Linked to Mental Health in Diabetes

Exposure to hypoglycaemia tracked over 10 weeks is not linked to depression, anxiety, diabetes distress, or fear of the condition in adults with type 1 diabetes or insulin-treated type 2 diabetes.

Child's Limp Revealed a Surprising 'Disease of the Past'

Even healthy, normal-weight children suffer malnourishment and its consequences

Record High GLP-1 Use; Intense Interval Exercise; Endometriosis and Androgens

— News and commentary from the endocrinology world

BMI Extremes Tied to Worse Pregnancy Outcomes With ART

BMI appears to have a greater impact on pregnancy continuation than on achieving initial implantation or pregnancy. Study findings suggest promoting proactive BMI optimization before treatment.

India's New Transgender Rules Worry Doctors, Disrupt Care

Mehr Khan, an Indian transgender woman, arrived for a routine hormone therapy appointment only to discover the crucial treatment had been suspended after a recent change in the law.

Kailera Shares Tumble on High Nausea Rates Despite Weight-loss Drug's Success

Kailera Therapeutics' shares dropped 10% on Tuesday after its oral weight-loss drug showed high rates ⁠of nausea and vomiting among participants in a late-stage trial in...

Pharmacist-Led Outreach Improves SGLT2 Inhibitor Uptake

Patients with chronic kidney disease and type 2 diabetes receiving pharmacist-led outreach were nearly twice as likely to start an SGLT2 inhibitor as those receiving usual care.

EMA Fast-tracks Review Of Revolutions' Experimental Pancreatic Cancer Pill

The European Medicines Agency said on Tuesday it has begun a rolling review of Revolution ⁠Medicines' experimental treatment for patients with metastatic pancreatic...

Cortisol Normalises by 4 Weeks After Stopping Contraceptives

Serum corticosteroid-binding globulin and total cortisol levels decrease rapidly and normalise within 4 weeks after the cessation of combined oral contraceptives, a Dutch study shows.

Middle-of-the-Night Eating Skews the Gut’s Circadian Clocks

Off-schedule eating disrupted intestinal circadian clocks in mice, which may help explain digestive and metabolic issues in night-shift workers.

Can Elevated MMP12 Levels Predict Pancreatic Cancer Risk?

Increased MMP12 levels are associated with a higher risk for pancreatic cancer, especially among patients diagnosed within 4 years of blood collection for immune marker analysis, a study reports.

Obesity Drugs Work Best for Youth With Lifestyle Support

The combination of obesity drugs with structured lifestyle programs ranks highest for yielding the greatest weight loss in children and adolescents, a network meta-analysis finds.

The Evolving Role of Non-Oral Contraceptive Strategies in Patient-Centered Care

The Evolving Role of Non-Oral Contraceptive Strategies in Patient-Centered Care

Current Evidence and Clinical Considerations in Non-Oral Contraceptive Care

Current Evidence and Clinical Considerations in Non-Oral Contraceptive Care

Navigating New Guidelines and Evidence in MASH: Noninvasive Assessments and Individualized Care

Navigating New Guidelines and Evidence in MASH: Noninvasive Assessments and Individualized Care

Unproven Peptides Need More Regulation, AMA Delegates Say

Let's "separate the science from the snake oil," says delegate

Recommended News For You

Pretreatment Liver Tests Often Overlooked in CDK4/6 Therapy

Higher Binge Drinking Rates Linked to New Cannabis Laws.

X-ray and radar technology combined to reduce cancer screening risks

Does pollution cause cancer?

Cardiorespiratory fitness lowers the risk of colon, lung, and prostate cancer in MEN and lowers mortality from these diseases.

Tipiracil hydrochloride and trifluridine tablets are approved by the USFDA for Natco Pharma.

For the creation of cutting-edge targeted radionuclide therapies in oncology, Bayer and Bicycle Therapeutics work together.

Recommended Articles For You

Sorafenib: Understanding the science behind a powerful cancer drug  

Unlocking the Potential of Leukemia Treatment: A New Hope for Patients 

Unlocking the Secrets of Improved Ovarian Cancer Survival Rates 

Practical Directions in Oncology in Daily Practice 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Inner Thoughts of Leonard Bernstein, the "Maestro".

2.

Patellar Resurfacing in Total Knee Replacement; Patient Messaging Trends

3.

Pancreatic Cancer: A Novel CD40 Agonist-Chemo Combo Shows Promise.

4.

Underprescribed for Alcohol Use Disorder is pharmacotherapy.

5.

Second Malignancy Risk With CAR T-Cell Therapy on Par With Other Treatments

1.

Uncovering the Hidden Signs: How to Recognize the Early Symptoms of Colon Cancer

2.

Breaking Down the Benefits and Risks of Hematopoietic Stem Cell Transplantation 

3.

Transformative Methods in Hematology for Better Care

4.

The Importance of Early Detection in Angiosarcoma: A Story of Survival 

5.

Unlocking The Power Of Cangrelor To Treat Heart Disease

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment

2.

Dacomitinib Case Presentation: Baseline Treatment and Current Status

3.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part I

4.

Efficient Management of First line ALK-rearranged NSCLC - Part IV

5.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part III

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot